Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in adults with Rifampicin susceptible Pulmonary Tuberculosis

Trial Identifier:	214912
Sponsor:	GlaxoSmithKline
Collaborator:	Click-TB Consortium
Start Date:	July 2022
Primary Completion Date:	May 2025
Study Completion Date:	May 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SOUTH_AFRICA	Bellville, SOUTH_AFRICA, 7530

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.